Max-Delbrück-Center for Molecular Medicine, Robert-Rössle Str. 10, 13125 Berlin, Germany.
Mol Oncol. 2013 Oct;7(5):929-43. doi: 10.1016/j.molonc.2013.05.003. Epub 2013 Jun 6.
MACC1, Metastasis associated in colon cancer 1, is a newly identified prognostic biomarker for colorectal cancer metastasis and patient survival, when determined in the primary tumor or patient blood. MACC1 induces cell motility and proliferation in cell culture and metastasis in mouse models. MACC1 acts as a transcriptional regulator of the receptor tyrosine kinase gene Met via binding to its promoter. However, no information about the promoter of the MACC1 gene and its transcriptional regulation has been reported so far. Here we report the identification of the MACC1 promoter using a promoter luciferase construct that directs transcription of MACC1. To gain insights into the essential domains within this promoter region, we constructed 5' truncated deletion constructs. Our results show that the region from -426 to -18 constitutes the core promoter and harbors functional motifs for the binding of AP-1, Sp1, and C/EBP transcription factors as validated by site directed mutagenesis study. Using electrophoretic mobility shift assay and chromatin immunoprecipitation assay, we demonstrated the physical interaction of these transcription factors to a minimal essential MACC1 core promoter sequence. Knock down of these transcription factors using RNAi strategy reduced MACC1 expression (P < 0.001), and resulted in decrease of cell migration (P < 0.01) which could be specifically rescued by ectopic overexpression of MACC1. In human colorectal tumors, expression levels of c-Jun and Sp1 correlated significantly to MACC1 (P = 0.0007 and P = 0.02, respectively). Importantly, levels of c-Jun and Sp1 also showed significant correlation to development of metachronous metastases (P = 0.01 and P = 0.001, respectively). This is the first study identifying the MACC1 promoter and its transcriptional regulation by AP-1 and Sp1. Knowledge of the transcriptional regulation of the MACC1 gene will implicate in enhanced understanding of its role in cancer progression and metastasis.
MACC1,结肠癌转移相关基因 1,是一种新发现的结直肠癌转移和患者生存的预后生物标志物,可在原发肿瘤或患者血液中确定。MACC1 在细胞培养中诱导细胞迁移和增殖,并在小鼠模型中诱导转移。MACC1 作为受体酪氨酸激酶基因 Met 的转录调节剂,通过与其启动子结合发挥作用。然而,迄今为止,尚无关于 MACC1 基因启动子及其转录调控的信息报道。在这里,我们使用启动子荧光素酶构建体鉴定了 MACC1 启动子,该构建体指导 MACC1 的转录。为了深入了解该启动子区域内的必需结构域,我们构建了 5' 截断缺失构建体。我们的结果表明,-426 至-18 的区域构成核心启动子,并包含用于 AP-1、Sp1 和 C/EBP 转录因子结合的功能基序,这一点通过定点突变研究得到了验证。通过电泳迁移率变动分析和染色质免疫沉淀分析,我们证明了这些转录因子与最小必需 MACC1 核心启动子序列的物理相互作用。使用 RNAi 策略敲低这些转录因子会降低 MACC1 表达(P < 0.001),并导致细胞迁移减少(P < 0.01),而通过异位过表达 MACC1 可特异性挽救这种减少。在人类结直肠肿瘤中,c-Jun 和 Sp1 的表达水平与 MACC1 显著相关(P = 0.0007 和 P = 0.02,分别)。重要的是,c-Jun 和 Sp1 的水平也与同时性转移的发生显著相关(P = 0.01 和 P = 0.001,分别)。这是首次鉴定 MACC1 启动子及其由 AP-1 和 Sp1 转录调控的研究。对 MACC1 基因转录调控的了解将有助于增强对其在癌症进展和转移中的作用的理解。